Filter by
News (106)
RSSThe EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021.
The United States, Japan and the European Union have agreed to renew their Trilateral partnership to address the global challenges posed by non-market policies and practices of third countries.
Today, the Commission launched an online consultation platform on the EU-US Trade and Technology Council (TTC), allowing stakeholders to share their views and provide common proposals on the work ahead.
Today the Commission launched Access2Procurement, a new expansion of the Access2Markets platform.
The Commission has initiated a series of actions to effectively implement and enforce the new Export Control Regulation (EU) 2021/821 that enters into force on 9 September 2021 following its adoption on 20 May 2021.
EU submits proposal seeking the commitment of WTO members for a multilateral trade action plan to expand production of COVID-19 vaccines.
the Commission services have concluded two examinations under the EU’s Trade Barriers Regulation (TBR)
Influential speakers gather to discuss the challenges facing global trade.
Today, the European Commission has introduced the principles of reciprocity and proportionality as new criteria to be considered for authorising exports under the transparency and authorisation mechanism for COVID-19 vaccine exports.
The Commission has today extended until end of June the transparency and authorisation mechanism for COVID-19 vaccine exports. This follows persistent delays in some of the deliveries of vaccines to the EU.